This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Büscher, K. Articles by Denner, J. Search for Related Content PubMed PubMed Citation Articles by Büscher, K. Articles by Denner, J.

Expression of Human Endogenous Retrovirus K in Melanomas and Melanoma Cell Lines

¹ Robert Koch-Institute and ² Department of Dermatology, Campus Charité-Mitte, Charité-University Medicine Berlin, Berlin, Germany

Requests for reprints: Joachim Denner, Robert Koch-Institute, Nordufer 20, D-13353 Berlin, Germany. Phone: 49-3045472800; Fax: 49-3045472801; E-mail: DennerJ{at}rki.de.

The human endogenous retrovirus K family (HERV-K) comprises 30 to 50 closely related proviruses, most of which are defective. In contrast to all other human endogenous retroviruses, some HERV-K proviruses have maintained open reading frames for all viral proteins. In addition to the structural proteins Gag and Env and the reverse transcriptase, two regulatory proteins (Rec and Np9) have been described. Malignant melanoma has the highest mortality among skin cancers and is particularly aggressive. To study the expression of HERV-K, a set of seven primers was developed that allows discrimination between full-length and spliced mRNA and mRNA from deleted and undeleted proviruses. Expression of full-length mRNA from deleted and undeleted proviruses was detected in all human cells investigated. Expression of spliced env and rec was detected in a teratocarcinoma cell line, in 45% of the metastatic melanoma biopsies, and in 44% of the melanoma cell lines. In normal neonatal melanocytes, spliced rec was detected but not spliced env. Viral proteins were shown to be expressed in primary melanomas, metastases, and melanoma cell lines by immunohistochemistry, immunofluorescence, and Western blot analyses using specific antisera. For the first time, antibodies against HERV-K were found in melanoma patients. Melanomas are, in addition to teratocarcinomas and human breast cancer, the third tumor type with enhanced expression of HERV-K.

This article has been cited by other articles:

				I. Georgiou, D. Noutsopoulos, E. Dimitriadou, G. Markopoulos, A. Apergi, L. Lazaros, T. Vaxevanoglou, K. Pantos, M. Syrrou, and T. Tzavaras Retrotransposon RNA expression and evidence for retrotransposition events in human oocytes Hum. Mol. Genet., April 1, 2009; 18(7): 1221 - 1228. [Abstract] [Full Text] [PDF]

				R. Contreras-Galindo, M. H. Kaplan, P. Leissner, T. Verjat, I. Ferlenghi, F. Bagnoli, F. Giusti, M. H. Dosik, D. F. Hayes, S. D. Gitlin, et al. Human Endogenous Retrovirus K (HML-2) Elements in the Plasma of People with Lymphoma and Breast Cancer J. Virol., October 1, 2008; 82(19): 9329 - 9336. [Abstract] [Full Text] [PDF]

				C. Voisset, R. A. Weiss, and D. J. Griffiths Human RNA "Rumor" Viruses: the Search for Novel Human Retroviruses in Chronic Disease Microbiol. Mol. Biol. Rev., March 1, 2008; 72(1): 157 - 196. [Abstract] [Full Text] [PDF]

				M. Dewannieux, F. Harper, A. Richaud, C. Letzelter, D. Ribet, G. Pierron, and T. Heidmann Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements Genome Res., December 1, 2006; 16(12): 1548 - 1556. [Abstract] [Full Text] [PDF]

				A. Buzdin, E. Kovalskaya-Alexandrova, E. Gogvadze, and E. Sverdlov At Least 50% of Human-Specific HERV-K (HML-2) Long Terminal Repeats Serve In Vivo as Active Promoters for Host Nonrepetitive DNA Transcription. J. Virol., November 1, 2006; 80(21): 10752 - 10762. [Abstract] [Full Text] [PDF]

				J.-P. Pichon, B. Bonnaud, P. Cleuziat, and F. Mallet Multiplex degenerate PCR coupled with an oligo sorbent array for human endogenous retrovirus expression profiling Nucleic Acids Res., March 22, 2006; 34(6): e46 - e46. [Abstract] [Full Text] [PDF]

				J. Humer, A. Waltenberger, A. Grassauer, M. Kurz, J. Valencak, R. Rapberger, S. Hahn, R. Lower, K. Wolff, M. Bergmann, et al. Identification of a Melanoma Marker Derived from Melanoma-Associated Endogenous Retroviruses Cancer Res., February 1, 2006; 66(3): 1658 - 1663. [Abstract] [Full Text] [PDF]